Research Paper Volume 13, Issue 1 pp 351—363
ADRB1 was identified as a potential biomarker for breast cancer by the co-analysis of tumor mutational burden and immune infiltration
Figure 6. VEGFR1-specific signaling pathway that HIF1A participates in. VEGFR1, vascular endothelial growth factor receptor 1; HIF1A, hypoxia-inducible factor 1.